Drug intelligence / Profile preview

Bacitracin Plus

Development stage
Phase 3
Lead developer
Randob Labs
Modality
Peptides, Small Molecules
Administration
Topical
01

Overview

Bacitracin Plus is an over-the-counter (OTC) topical antibiotic ointment marketed by CrossingWell (formerly Randob Labs). It is indicated for the prevention and treatment of minor skin infections resulting from minor cuts, scrapes, and burns. The active ingredient, bacitracin, is a cyclic polypeptide antibiotic that inhibits bacterial cell wall synthesis. It functions by binding to C55-isoprenyl pyrophosphate, a lipid carrier molecule, thereby preventing the dephosphorylation and recycling of the carrier required to transport peptidoglycan subunits across the bacterial cell membrane. This mechanism is primarily bactericidal against Gram-positive organisms. Despite the 'Plus' suffix, which often indicates a combination product in the topical antibiotic market, the product is specified as a single-ingredient antibiotic ointment in company documentation.

Brand names
Bacitracin PlusBacitracyin Plus
Other names
bacitracinbacitracin zincBacitracin Zinc Ointment
02

Targets

IDE (Insulin-degrading enzyme)A2M (Alpha-2-macroglobulin)C55-PP (Undecaprenyl pyrophosphate)

Beyond the preview

Go deeper on Bacitracin Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacitracin Plus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call